Lifeboat Foundation

Scientists at Kyoto University’s Institute for Cell-Material Sciences have discovered a novel cluster compound that could prove useful as a catalyst. Compounds, called polyoxometalates, that contain a large metal-oxide cluster carry a negative charge. They are found everywhere, from anti-viral medicines to rechargeable batteries and flash memory devices.

The new cluster compound is a hydroxy-iodide (HSbOI) and is unusual, as it has large, positively charged clusters. Only a handful of such positively charged cluster compounds have been found and studied.

“In science, the discovery of new material or molecule can create a new science,” says Kyoto University chemist Hiroshi Kageyama. “I believe that these new positively charged clusters have great potential.”

The Beginnings of a biotechnology revolution in Saudi Arabia?

The Saudi royal family, led by king Salman bin Abdulaziz have announced the formation of a non-profit research foundation which intends to spend $1 billion of the countries considerable annual oil revenue on supporting anti-aging research. If such funding materialises, it will make Saudi Arabia the single greatest financial contributor to longevity research.

The Saudi royal family aims to distribute this funding through a non-profit organisation called the Hevolution Foundation 0, which was founded by Dr Mehmood Khan, formerly of the Mayo Clinic. In a formal introduction to the Hevolution Foundation, Dr Khan had the following to say.

Enovix, based in Fremont, California, is developing 3D silicon lithium-ion batteries with faster charging times and higher energy densities than the current generation of cells.

A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a study by researchers at Washington University School of Medicine in St. Louis and colleagues at other institutions.

The technology, which uses so-called optical microring resonators, potentially could be developed into a rapid diagnostic test for the deadly Ebola virus disease, which kills up to 89% of infected people. Since it was discovered in 1976, Ebola virus has caused dozens of outbreaks, mostly in central and west Africa. Most notable was an outbreak that began in 2014 and killed more than 11,000 people in Guinea, Sierra Leone and Liberia; in the U.S., the virus caused 11 cases and two deaths. A rapid, early diagnostic could help public health workers track the virus’ spread and implement strategies to limit outbreaks.